Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US9957283B1 · US · B1
| Field | Value |
|---|---|
| Publication number | US-9957283-B1 |
| Application number | US-201715784585-A |
| Country | US |
| Kind code | B1 |
| Filing date | Oct 16, 2017 |
| Priority date | Jun 16, 2014 |
| Publication date | May 1, 2018 |
| Grant date | May 1, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel processes, and intermediates, for making alkylated arylpiperazine and alkylated arylpiperidine compounds of the general formulas (I) and (VII), respectively wherein, R 1 and R 2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR 3 R 4 , OR 5 , or SR 5 , where R 3 and R 4 are individually selected from acyl or sulfonyl, and where R 5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.
Opening claim text (preview).
What is claimed is: 1. A method of preparing wherein Y is selected from the group consisting of and Ar is selected from the group consisting of provided that when Y is then Ar is or when Y is then Ar is or when Y is then Ar is comprising (i) alkylating 1,3,2-dioxathiane 2,2-dioxide having the formula with in the presence of base selected from potassium carbonate, sodium carbonate, magnesium carbonate, calcium carbonate, potassium hydroxide, sodium hydroxide, magnesium hydroxide or calcium hydroxide, to form the corresponding alkylation compound of the formula wherein Q is potassium, sodium, magnesium or calcium, (ii) hydrolyzing the alkylation compound of step (i) with aqueous acid to obtain the corresponding hydroxyl compound of formula wherein Y is selected from the group consisting of (iii) converting the compound of formula of step (ii) to the corresponding alkylating agent compound of formula wherein LG is an aryl sulfonate or alkyl sulfonate, and (iv) alkylating the compound of formula of step (iii) with the compound of formula wherein Ar is selected from the group consisting of in the presence of base selected from potassium carbonate, sodium carbonate, magnesium carbonate, calcium carbonate, potassium hydroxide, sodium hydroxide, magnesium hydroxide or calcium hydroxide, provided that when Y is then Ar is or when Y is then Ar is or when Y is then Ar is 2. The process of claim 1 wherein the base of steps (i) and (iv) is potassium carbonate. 3. The process of claim 1 wherein LG is methylsulfonate. 4. The process of claim 1 wherein Y is and Ar is 5. The process of claim 1 wherein Y is and Ar is 6. The process of claim 1 wherein Y is and Ar is
having no double bonds between ring members or between ring members and non-ring members · CPC title
linked by a carbon chain containing alicyclic rings · CPC title
condensed with a ring other than six-membered · CPC title
in which the condensed system contains three hetero rings · CPC title
with hetero atoms directly attached to the ring sulfur atom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.